Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG) Data ...
Randomized trials of venetoclax plus anti-CD20 antibodies as first-line treatment in fit patients (i.e., those with a low burden of coexisting conditions) with advanced chronic lymphocytic leukemia ...
Please provide your email address to receive an email when new articles are posted on . Zongertinib conferred benefits in PFS and response as a first-line treatment option for HER2-mutant advanced non ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results